RIPK3, a key kinase of necrotizing apoptosis, is significantly down-regulated in human colorectal cancer (CRC), and its expression has anti-inflammatory and anti-tumor effects in the intestine [17]. The gene discussed is RIPK3; the disease is neoplasm.